Epidemiology of stroke in the elderly in the Nordic countries. incidence, survival, prevalence and risk factors

Norsk Epidemiologi

Volumn 22, Issue 2, 2012, Pages 121-126

  Engstad, Torgeir ^a   Engstad, Tora Torgersen ^b   Viitanen, Matti ^c   Ellekjær, Hanne ^d  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b DIAKONHJEMMET HOSPITAL   (Norway)

^c UNIVERSITY OF TURKU   (Finland)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; CARDIOEMBOLIC STROKE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INCIDENCE; LIFE EXPECTANCY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWAY; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; STROKE PATIENT; SURVIVAL RATE;

EID: 84870865011     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: 10.5324/nje.v22i2.1557     Document Type: Article

References (39)

1. Truelsen T, Bonita R, Jamrozik K. Surveillance of stroke: a global perspective. Int J Epidemiol 2001; 30 (Suppl 1): S11-16.
2. Neurology in the elderly: more trials urgently needed. Lancet Neurol 2009; 8: 969
3. Sudlow CL, Warlow CP. Comparing stroke incidence worldwide: what makes studies comparable? Stroke 1996; 27: 550-558.
4. Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8: 355-369.
5. Ellekjaer H, Selmer R. [Stroke--similar incidence, better prognosis]. Tidsskr Nor Lægeforen 2007; 127: 740-743.
6. Truelsen T, Piechowski-Jozwiak B, Bonita R, et al. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 2006; 13: 581-598.
7. Naess H, Waje-Andreassen U, Brogger J, et al. [Patients with acute cerebral infarction admitted to stroke unit]. Tidsskr Nor Lægeforen 2011; 131: 814-818.
8. Meretoja A. PERFECT stroke: PERFormance Effectiveness, and Cost of treatment episodes in stroke. University of Helsinki, 2011.
9. Modig K, Drefahl S, Andersson T, et al. The aging population in Sweden: can declining incidence rates in MI, stroke and cancer counterbalance the future demographic challenges? Eur J Epidemiol 2012; 27: 139-145.
10. Hallstrom B, Jonsson AC, Nerbrand C, et al. Stroke incidence and survival in the beginning of the 21st century in southern Sweden: comparisons with the late 20th century and projections into the future. Stroke 2008; 39: 10-15.
11. Sivenius J, Torppa J, Tuomilehto J, et al. Modelling the burden of stroke in Finland until 2030. Int J Stroke 2009; 4: 340-345.
12. Zhang Y, Chapman AM, Plested M, et al. The incidence, prevalence, and mortality of stroke in France, Germany, Italy, Spain, the UK, and the US: A literature review. Stroke Res Treat 2012; 2012: 436125.
13. Ellekjaer H. Epidemiological studies of stroke in a Norwegian population: incidence, risk factors and prognosis. Verdal, HUNT Research Center, Department of Community Medicine and General Practice, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), 2000.
14. Appelros P, Nydevik I, Seiger A, et al. High incidence rates of stroke in Orebro, Sweden: Further support for regional incidence differences within Scandinavia. Cerebrovasc Dis 2002; 14: 161-8.
15. Russo T, Felzani G, Marini C. Stroke in the very old: a systematic review of studies on incidence, outcome, and resource use. J Aging Res 2011; 2011: 108785.
16. Vartiainen E, Jousilahti P, Alfthan G, et al. Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol 2000; 29: 49-56.
17. http://statbank.ssb.no/statistikkbanken.
18. Sarti C, Stegmayr B, Tolonen H, et al. Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA Project. Stroke 2003; 34: 1833-1840.
19. Zhu L, Fratiglioni L, Guo Z, et al. Association of stroke with dementia, cognitive impairment, and functional disability in the very old: a population-based study. Stroke 1998; 29: 2094-2099.
20. Hornsten C, Molander L, Gustafson Y. The prevalence of stroke and the association between stroke and depression among a very old population. Arch Gerontol Geriatr 2012; 55: 555-559.
21. Rastas S, Verkkoniemi A, Polvikoski T, et al. Atrial fibrillation, stroke, and cognition: a longitudinal population-based study of people aged 85 and older. Stroke 2007; 38: 1454-1460.
22. Andersen KK, Andersen ZJ, Olsen TS. Age- and gender-specific prevalence of cardiovascular risk factors in 40,102 patients with first-ever ischemic stroke: a Nationwide Danish Study. Stroke 2010; 41: 2768-2774.
23. Rojas JI, Zurru MC, Romano M, et al. Acute ischemic stroke and transient ischemic attack in the very old -risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur J Neurol 2007; 14: 895-899.
24. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898.
25. Bulpitt CJ, Beckett NS, Peters R, et al. Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET). J Hum Hypertens 2012; 26: 157-163.
26. Ellekjaer H, Holmen J, Vatten L. Blood pressure, smoking and body mass in relation to mortality from stroke and coronary heart disease in the elderly. A 10-year follow-up in Norway. Blood Pressure 2001; 10: 156-163.
27. Walldius G, Aastveit AH, Jungner I. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study. J Intern Med 2006; 259: 259-266.
28. Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 1670-1681.
29. Afilalo J, Duque G, Steele R, et al. Statins for secondary prevention in elderly patients: a hierarchical Bayesian meta-analysis. J Am Coll Cardiol 2008; 51: 37-45.
30. Upmeier E, Lavonius S, Heinonen P, et al. Longitudinal changes in serum lipids in older people the Turku elderly study 1991-2006. Age Ageing 2011; 40: 280-283.
31. Chen RL, Balami JS, Esiri MM, et al. Ischemic stroke in the elderly: an overview of evidence. Nature Rev Neurol 2010; 6: 256-265.
32. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 469-473.
33. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
34. Wang J, Ruotsalainen S, Moilanen L, et al. The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland. Stroke 2008; 39: 1078-1083.
35. Mahonen M, Salomaa V, Keskimaki I, et al. The feasibility of combining data from routine Hospital Dischargeand Causes-of-Death Registers for epidemiological studies on stroke. Eur J Epidemiol 2000; 16: 815-817.
36. Ricci S, Celani MG, La Rosa F, et al. SEPIVAC: a community-based study of stroke incidence in Umbria, Italy. J Neurol Neurosurg Psychiatry 1991; 54: 695-698.
37. Ihle-Hansen H, Thommessen B, Wyller TB, et al. Risk factors for and incidence of subtypes of ischemic stroke. Funct Neurol 2012; 27: 35-40.
38. Arboix A, Miguel M, Ciscar E, et al. Cardiovascular risk factors in patients aged 85 or older with ischemic stroke. Clin Neurol Neurosurg 2006; 108: 638-643.
39. Kammersgaard LP, Jorgensen HS, Reith J, et al. Short- and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study. Age Ageing 2004; 33: 149-154.